Back to news
Regulation & Compliance Published on March 10, 2025
1 min read
In the European Union, peptides intended for in vitro research are legally marketable under certain strict conditions:
They must not be presented as medicines They are not intended for human or animal consumption They must be sold exclusively for scientific research purposes
The REACH regulation (EC No 1907/2006) governs chemical substances on the European market. Serious manufacturers and distributors respect these obligations and can provide compliance documents upon request.
For buyers, some essential quality criteria:
Certificate of analysis (CoA) provided for each batch Purity verified by HPLC (minimum 98%) Identity confirmed by mass spectrometry Storage and transport conditions respected
Peptides sold as "dietary supplements" or with health claims are illegal in most EU countries if they do not have a marketing authorization (MA).
At Fast Peptides, we scrupulously respect this regulatory framework and provide complete documentation for each order.
Regulation & Compliance
Research peptides vs pharmaceutical peptides: all the differences to know
April 23, 2026
Regulation & Compliance
Research peptides in France: the complete 2026 guide
April 23, 2026
Regulation & Compliance
Peptides and Professional Sports: WADA Anti-Doping Rules
April 15, 2025
Regulation & Compliance
FDA and BPC-157: Understanding the "Category 2" Classification
April 1, 2025